Trial
NCT03982004
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
Merck Sharp & Dohme LLC
Condition
Metastatic Breast Cancer
Intervention
Epicutaneous cryoimmunotherapy
Why stopped
Sponsor decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-21